Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about LOXL3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | LOXL3 |
| Related Diseases | Glioma |
| Related Pathways | Catalytic Motifs |
Knowledge base pages for this entity
graph TD
LOXL3["LOXL3"]
LOXL3 -->|"involved_in"| Cancer_Progression["Cancer Progression"]
LOXL3 -->|"involved_in"| Extracellular_Matrix_Remodelin["Extracellular Matrix Remodeling"]
LOXL3 -->|"involved_in"| Extracellular_Matrix["Extracellular Matrix"]
LOXL3 -->|"involved_in"| Tissue_Homeostasis["Tissue Homeostasis"]
LOXL3 -->|"regulates"| Innate_Immunity["Innate Immunity"]
LOXL3 -->|"regulates"| Adaptive_Immunity["Adaptive Immunity"]
LOXL3 -->|"expressed in"| Endostyle["Endostyle"]
LOXL3 -->|"expressed in"| Liver["Liver"]
LR_LOXL3["LR.LOXL3"] -->|"interacts"| LOXL3
GENES["GENES"] -->|"target for"| LOXL3
LOXL1_4["LOXL1-4"] -->|"expressed in"| LOXL3
LOX["LOX"] -->|"inhibits"| LOXL3
LOXL2["LOXL2"] -->|"expressed in"| LOXL3
RNA["RNA"] -->|"expressed in"| LOXL3
AND["AND"] -->|"inhibits"| LOXL3| Target | Relation | Type | Str |
|---|---|---|---|
| Cancer Progression | involved_in | process | 0.95 |
| Extracellular Matrix Remodeling | involved_in | process | 0.95 |
| Extracellular Matrix | involved_in | process | 0.95 |
| Cancer Progression | promotes | process | 0.95 |
| Tissue Homeostasis | involved_in | process | 0.92 |
| Glioma | associated_with | disease | 0.92 |
| Innate Immunity | regulates | process | 0.90 |
| Adaptive Immunity | regulates | process | 0.90 |
| Endostyle | expressed_in | cell_type | 0.90 |
| Liver | expressed_in | cell_type | 0.90 |
| Vertebrate Immunity | involved_in | process | 0.88 |
| Glycolipid Metabolism | regulates | process | 0.85 |
| Immune-Metabolic Homeostasis | associated_with | process | 0.85 |
| Catalytic Motifs | associated_with | mechanism | 0.85 |
| Ecm Remodeling | involved_in | process | 0.85 |
| Phytohemagglutinin | upregulates | compound | 0.85 |
| Lipopolysaccharide | upregulates | compound | 0.85 |
| glycolipid metabolism | modulates | pathway | 0.85 |
| Metabolism | involved_in | process | 0.82 |
| Immunity | regulates | biological_process | 0.80 |
| PHA | modulates | compound | 0.80 |
| tumor progression | promotes | process | 0.80 |
| PHA | upregulates | compound | 0.80 |
| LOX | interacts_with | gene | 0.80 |
| LOXL1 | interacts_with | gene | 0.75 |
| Ms | therapeutic_target | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Als | implicated_in | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| CANCER | inhibits | gene | 0.60 |
| LOX | inhibits | gene | 0.60 |
| LOXL1 | therapeutic_target | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| LOX/LOXL1-4 | therapeutic_target | gene | 0.60 |
| LOXL2 | therapeutic_target | gene | 0.60 |
| LOXL1-4 | therapeutic_target | gene | 0.60 |
| LOX | regulates | gene | 0.60 |
| LOXL1 | associated_with | gene | 0.60 |
| LR.LOXL3 | implicated_in | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| LOX/LOXL1-4 | associated_with | gene | 0.60 |
| LOXL1-4 | associated_with | gene | 0.60 |
| Lipid Metabolism | associated_with | pathway | 0.60 |
| Immune Response | associated_with | pathway | 0.60 |
| LOXL1 | expressed_in | gene | 0.60 |
| LR.LOXL3 | regulates | gene | 0.60 |
| LOXL1 | stabilizes | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| LR.LOXL3 | interacts_with | gene | 0.85 |
| GENES | therapeutic_target | gene | 0.60 |
| LOXL1-4 | expressed_in | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| LOX | inhibits | gene | 0.60 |
| LOXL2 | expressed_in | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| LOX/LOXL1-4 | expressed_in | gene | 0.60 |
| LOXL1-4 | stabilizes | gene | 0.60 |
| LOX | regulates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| LOX/LOXL1-4 | stabilizes | gene | 0.60 |
| LOX/LOXL1-4 | therapeutic_target | gene | 0.60 |
| RNA | therapeutic_target | gene | 0.60 |
| LOX/LOXL1-4 | associated_with | gene | 0.60 |
| LOXL1 | expressed_in | gene | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| LOXL1 | stabilizes | gene | 0.60 |
| LR.LOXL3 | regulates | gene | 0.60 |
| LOX | associated_with | gene | 0.60 |
| LOXL1 | associated_with | gene | 0.60 |
| LOX | expressed_in | gene | 0.60 |
| GBM | co_expressed_with | gene | 0.60 |
| LOX | co_expressed_with | gene | 0.60 |
| LOXL1 | co_expressed_with | gene | 0.60 |
| LOXL2 | associated_with | gene | 0.55 |
| LOXL2 | inhibits | gene | 0.55 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||